| Financial Year |
March 31 2023 |
| Monetary Funds |
927,003,446.00 |
| Held-for-trading Financial Assets |
102,388,000.00 |
| Notes Receivable |
22,790,649.58 |
| Accounts Receivable |
502,181,829.50 |
| Advances to Suppliers |
192,888,649.11 |
| Other Receivables |
25,110,598.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
765,140,939.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,283,104.60 |
| Total Current Assets |
2,590,879,291.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,771,700.23 |
| Investment Properties |
-- |
| Fixed Assetes |
865,441,901.88 |
| Under-construction Projects |
123,603,777.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
181,494,492.26 |
| R&D expenses |
-- |
| Goodwill |
16,485,082.41 |
| Long-Term Deferred and Prepaid Expenses |
31,785,614.85 |
| Deferred Income Tax Assets |
53,014,531.74 |
| Other Non-Current Assets |
25,965,748.59 |
| Sub-Total of Non-Current Assets |
1,392,228,678.72 |
| Total Assets |
3,983,107,970.20 |
| Short-Term Loans |
524,712,283.07 |
| Trading Financial liabilities |
8,823,499.22 |
| Notes Payable |
372,109,262.81 |
| Accounts Payable |
546,488,385.02 |
| Accounts Received In Advance |
13,623,646.33 |
| Employee Compensation Payable |
26,101,839.44 |
| Taxes Payable |
17,616,692.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,925,336.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,597,441.45 |
| Other Current Liabilities |
15,049,034.91 |
| Sub-Total of Current Liabilities |
2,137,058,450.24 |
| Long-term Loans |
52,482,194.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,801,643.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,937,766.20 |
| Total Liabilities |
2,207,996,216.44 |
| Paid-In Capital(Or Share Stock) |
575,406,349.00 |
| Capital Surplus |
1,201,471,706.39 |
| Surplus Reserve |
68,069,032.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-80,463,647.76 |
| Minority Stockholder's Interest |
39,798,865.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,735,312,888.62 |
| Owner's Equity（Stockholder's Equity） |
1,775,111,753.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,983,107,970.20 |
